Pioneering AI Drug Discovery | Recursion
Our data and the Recursion OS enable us to train intelligent machine learning models for AI drug discovery and development, which help us rapidly identify new targets and design highly optimized …
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results ...
Dec 31, 2025 · Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple …
Recursion's Drug Discovery Pipeline | Recursion
Explore Recursion's dynamic drug discovery pipeline. Witness the innovations and breakthroughs in our journey. Dive deeper with us today!
Careers at Recursion: Join Our Mission | Recursion
Embark on a career journey with Recursion. Dive into opportunities, culture, and the impact you can make. Apply to work with us today!
Our Unique Approach to AI Drug Discovery | Recursion
Recursion's TechBio approach: The future of AI drug discovery In traditional drug discovery, 90% of drugs fail in clinical trials, after more than a decade in development and ~$2 billion in costs. We’re …
Recursion Pharmaceuticals, Inc. - Recursion and Exscientia, two leaders ...
Nov 20, 2024 · Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered …
Meet our Team | Recursion
Get acquainted with the brilliant minds behind Recursion. Dive into our team's passion, expertise, and vision. Read more about our team today!
Press Releases & Recursion News | Recursion
Sep 1, 2017 · Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!
Technology - Recursion OS:
Central to our mission is the Recursion Operating System (OS), a platform powered by one of the world’s largest proprietary biological and chemical datasets. Instead of looking narrowly at a handful …
Recursion Pharmaceuticals, Inc. - Press Releases
Feb 12, 2026 · The Investor Relations website contains information about Recursion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.